Protective Effects of Lanostane Triterpenoids from Chaga Mushroom in Human Keratinocytes, HaCaT Cells, Against Inflammatory and Oxidative Stresses
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Inotodiol, a lanostane-type triterpenoid, and many phytochemicals from Chaga mushrooms have been investigated for various allergic diseases. However, the anti-aging and anti-inflammatory activities of inotodiol under different types of oxidative stress and the impact of inotodiol on collagen and hyaluronan synthesis have not been sufficiently studied. Lanostane triterpenoids-rich concentrate, which contained 10% inotodiol as major (inotodiol concentrate), was prepared from Chaga and compared with pure inotodiol in terms of anti-inflammatory activities on a human keratinocyte cell line, HaCaT cells, under various stimulations such as stimulation with ultraviolet (UV) B or tumor necrosis factor (TNF)-α. In stimulation with TNF-α, interleukin (IL)-1β, IL-6, and IL-8 genes were significantly repressed by 0.44~4.0 μg/mL of pure inotodiol. UVB irradiation induced the overexpression of pro-inflammatory cytokines, but those genes were significantly suppressed by pure inotodiol or inotodiol concentrate. Moreover, pure inotodiol/inotodiol concentrate could also modulate the synthesis of collagen and hyaluronic acid by controlling COL1A2 and HAS2/3 expression, which implies a crucial role for pure inotodiol/inotodiol concentrate in the prevention of skin aging. These results illuminate the anti-inflammatory and anti-aging effects of pure inotodiol/inotodiol concentrate, and it is highly conceivable that pure inotodiol and inotodiol concentrate could be promising natural bioactive substances to be incorporated in therapeutic and beautifying applications.
Salazar J, Ortega A, Perez J, Garrido B, Santeliz R, Galban N Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40006060 PMC: 11859979. DOI: 10.3390/ph18020247.
Chemical Content and Cytotoxic Activity on Various Cancer Cell Lines of Chaga () Growing on and .
Raal A, Kaldmae H, Kutt K, Jurimaa K, Silm M, Bleive U Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204121 PMC: 11357148. DOI: 10.3390/ph17081013.
Paterska M, Czerny B, Cielecka-Piontek J Nutrients. 2024; 16(16).
PMID: 39203946 PMC: 11356820. DOI: 10.3390/nu16162810.
A brief overview of the medicinal and nutraceutical importance of (chaga) mushrooms.
Camilleri E, Blundell R, Baral B, Karpinski T, Aruci E, Atrooz O Heliyon. 2024; 10(15):e35638.
PMID: 39170453 PMC: 11336990. DOI: 10.1016/j.heliyon.2024.e35638.
Fu Y, Xie J, Zhang W, Zhang X, Zhang X, Xu M Heliyon. 2024; 10(15):e34321.
PMID: 39144947 PMC: 11320485. DOI: 10.1016/j.heliyon.2024.e34321.